In mice, B cells have been suggested to have both detrimental and protective effects in MASLD, whereas CD8+ T cells promote liver fibrosis resolution [23,38,39,40]. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatotic liver disease.